Cargando…
The epidemiologic status of gynecologic cancer in Thailand
Between the years of 2010–2012, it was estimated there were a total of 112,392 new cases of cancers in Thailand, thus, the total age-standardized rate (ASR) per 100,000 is 137.6. In regards to the most prevalent types of cancer in female, breast cancer has the highest ASR, followed by cervical cance...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078827/ https://www.ncbi.nlm.nih.gov/pubmed/27775261 http://dx.doi.org/10.3802/jgo.2016.27.e65 |
_version_ | 1782462458743488512 |
---|---|
author | Wilailak, Sarikapan Lertchaipattanakul, Nuttapong |
author_facet | Wilailak, Sarikapan Lertchaipattanakul, Nuttapong |
author_sort | Wilailak, Sarikapan |
collection | PubMed |
description | Between the years of 2010–2012, it was estimated there were a total of 112,392 new cases of cancers in Thailand, thus, the total age-standardized rate (ASR) per 100,000 is 137.6. In regards to the most prevalent types of cancer in female, breast cancer has the highest ASR, followed by cervical cancer (ASR=14.4); liver and bile duct cancer; colon and rectum cancer; trachea, bronchus and lung cancer; ovarian cancer (ASR=6.0); thyroid cancer; non-Hodgkin lymphoma and uterine cancer (ASR=4.3). The trend of cervical cancer in Thailand is decreasing, one key factor in making this possible was the employment of dual tract strategy (Pap smear and visual inspection with acetic acid [VIA]) by the government in 2005. In the future, the government is also considering integrating human papillomavirus (HPV) vaccination into the national immunization program, which may assist in the prevention of cervical cancer. By studying the statistical data of gynecologic cancer, it will be possible to formulate measures for the prevention, control and treatment of gynecologic cancer. Eventually, it will potentially improve the quality of life (QoL) of patients as well as decrease the mortality rate caused by gynecologic cancer. |
format | Online Article Text |
id | pubmed-5078827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-50788272016-11-01 The epidemiologic status of gynecologic cancer in Thailand Wilailak, Sarikapan Lertchaipattanakul, Nuttapong J Gynecol Oncol Expert Report Between the years of 2010–2012, it was estimated there were a total of 112,392 new cases of cancers in Thailand, thus, the total age-standardized rate (ASR) per 100,000 is 137.6. In regards to the most prevalent types of cancer in female, breast cancer has the highest ASR, followed by cervical cancer (ASR=14.4); liver and bile duct cancer; colon and rectum cancer; trachea, bronchus and lung cancer; ovarian cancer (ASR=6.0); thyroid cancer; non-Hodgkin lymphoma and uterine cancer (ASR=4.3). The trend of cervical cancer in Thailand is decreasing, one key factor in making this possible was the employment of dual tract strategy (Pap smear and visual inspection with acetic acid [VIA]) by the government in 2005. In the future, the government is also considering integrating human papillomavirus (HPV) vaccination into the national immunization program, which may assist in the prevention of cervical cancer. By studying the statistical data of gynecologic cancer, it will be possible to formulate measures for the prevention, control and treatment of gynecologic cancer. Eventually, it will potentially improve the quality of life (QoL) of patients as well as decrease the mortality rate caused by gynecologic cancer. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2016-11 2016-10-10 /pmc/articles/PMC5078827/ /pubmed/27775261 http://dx.doi.org/10.3802/jgo.2016.27.e65 Text en Copyright © 2016. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Expert Report Wilailak, Sarikapan Lertchaipattanakul, Nuttapong The epidemiologic status of gynecologic cancer in Thailand |
title | The epidemiologic status of gynecologic cancer in Thailand |
title_full | The epidemiologic status of gynecologic cancer in Thailand |
title_fullStr | The epidemiologic status of gynecologic cancer in Thailand |
title_full_unstemmed | The epidemiologic status of gynecologic cancer in Thailand |
title_short | The epidemiologic status of gynecologic cancer in Thailand |
title_sort | epidemiologic status of gynecologic cancer in thailand |
topic | Expert Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078827/ https://www.ncbi.nlm.nih.gov/pubmed/27775261 http://dx.doi.org/10.3802/jgo.2016.27.e65 |
work_keys_str_mv | AT wilailaksarikapan theepidemiologicstatusofgynecologiccancerinthailand AT lertchaipattanakulnuttapong theepidemiologicstatusofgynecologiccancerinthailand AT wilailaksarikapan epidemiologicstatusofgynecologiccancerinthailand AT lertchaipattanakulnuttapong epidemiologicstatusofgynecologiccancerinthailand |